Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Kelly highlights several stories of survival and determination.
Medtronic and Bayer have announced that they will partner over the next several years to develop “innovative next-generation diabetes management systems for patients...
New insulins on the horizon are designed to be taken three times a week. We’ve just heard that research at Novo Nordisk is moving quickly on two new insulins, one dubbed...
Testing blood sugar levels day in and day out isn't always fun for kids. But what if they were rewarded with points for each test that was within range and also for...
The FDA’s decision on Bydureon was a shocker. We break down this decision and discuss why we view it as such a disappointment.
(S)he said what?!?
In late 2010, Merck announced that it had acquired SmartCells, a small Massachusetts-based company that is developing a smart insulin product aptly named SmartInsulin...
We had a great time at AADE learning more about what DexCom has in the works—primarily this relates to work toward FDA approval for its fourth-generation continuous...
Will CGM be for the masses or just the highly motivated? See Jim Hirsch's thoughts on the matter.
Contrave, a novel weight-loss drug made by Orexigen. In late January, in a surprise move to many in light of the positive FDA Advisory Committee meeting (see New Now...
Ever get the winter blues? If you're like one member of our team, it may be hard to stay motivated and exercise in the winter months. We checked out the new Bayer and...
Exciting findings from the largest diabetes meeting of the year, the American Diabetes Association’s annual Scientific Sessions.
Pass the streusel: the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria.
David Simmons, President and General Manager of Pfizer’s Established Products Business Unit, and Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon, shake...
Kelly muses on the future of GLP-1 agonists and bariatric surgery.
When your blood sugar gets too high, don’t you wish you could just filter the sugar out of your blood stream? In fact, along with waste products, the kidneys filter...
The JDRF moves forward internationally to advance the artificial pancreas. The JDRF has partnered with a group of European academics and members of industry who are...
We recently wrote an article on a full-featured “detachable” tubeless insulin pump, Medingo’s Solo MicroPump Insulin Delivery System . We had previously mentioned that...
Imagine dreaming about waking up alive inside a body bag. Vietnam veteran Urban Miyares did, but it wasn’t exactly a dream...
ASP1941 (SGLT2 inhibitor for type 2).

Pages